Bactramin


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 29.3%
Prophylaxis 13.8%
Infection Prophylaxis 10.3%
Rheumatoid Arthritis 6.9%
Osteoporosis 4.3%
Febrile Neutropenia 3.4%
Idiopathic Pulmonary Fibrosis 3.4%
Acute Lymphocytic Leukaemia 2.6%
Anaplastic Astrocytoma 2.6%
Chronic Hepatitis C 2.6%
Gastritis 2.6%
Hepatitis C 2.6%
Insomnia 2.6%
Pneumocystis Jiroveci Pneumonia 2.6%
Adverse Event 1.7%
Antifungal Prophylaxis 1.7%
Aplastic Anaemia 1.7%
Blood Immunoglobulin G Decreased 1.7%
Brain Oedema 1.7%
Hypertension 1.7%
White Blood Cell Count Decreased 28.6%
Agranulocytosis 14.3%
Cardiac Failure 9.5%
Septic Shock 9.5%
Drug Eruption 4.8%
Erythema Multiforme 4.8%
Oedema 4.8%
Pneumocystis Jirovecii Pneumonia 4.8%
Pseudomembranous Colitis 4.8%
Rash Pustular 4.8%
Sputum Retention 4.8%
White Blood Cell Count Increased 4.8%
Concomitant
Product Used For Unknown Indication 25.1%
Prophylaxis 15.1%
Drug Use For Unknown Indication 11.2%
Rheumatoid Arthritis 7.7%
Plasma Cell Myeloma 6.8%
Infection Prophylaxis 5.1%
Immune Thrombocytopenic Purpura 3.8%
Hypertension 3.2%
Aplastic Anaemia 2.8%
Myelodysplastic Syndrome 2.4%
Systemic Lupus Erythematosus 2.4%
Insomnia 1.9%
Psychotic Disorder 1.9%
Prophylaxis Against Gastrointestinal Ulcer 1.8%
Antifungal Prophylaxis 1.7%
Multiple Myeloma 1.7%
Osteoporosis 1.6%
Prophylaxis Against Graft Versus Host Disease 1.4%
Acute Myeloid Leukaemia 1.2%
Adult T-cell Lymphoma/leukaemia 1.2%
White Blood Cell Count Decreased 15.9%
Pyrexia 10.2%
Interstitial Lung Disease 9.1%
Renal Impairment 8.0%
Febrile Neutropenia 6.8%
Renal Disorder 5.7%
White Blood Cell Count Increased 5.7%
Asphyxia 4.5%
Sepsis 4.5%
Blood Uric Acid Increased 3.4%
Influenza 3.4%
Pneumonia 3.4%
Vomiting 3.4%
Breast Cancer Female 2.3%
Drug Eruption 2.3%
Femoral Neck Fracture 2.3%
Gastric Cancer 2.3%
Herpes Zoster 2.3%
Myocardial Infarction 2.3%
Oedema 2.3%

Drug Data